Microbe-based pharmaceutical agents

  • 2018

The client

ActoBio Therapeutics™ is pioneering a new class of safe, effective and easy-to-use treatments called ActoBiotics™ for autoimmune and allergic disorders based on the well-characterized food-grade bacterium Lactococcus lactis.

The challenge

ActoBio asked us to create a new brand identity and associated assets to communicate their scientific breakthroughs.

Dr. Pieter Rottiers
CEO | ActoBio Therapeutics

"The team of joyful hard working ‘monkeys’ did a great job at rebranding our company. During this process we benefited from Monkeys not Donkeys broad experience and network."

Our expertise

We carried out a full rebranding including a new logo & tagline, key visual and set of custom made icons and infographics that allow the ActoBio team to communicate their message in a compelling way. We then created various hard copy and digital communication assets including a new website with custom disease icons, a new PowerPoint template based on the new brand guidelines. We updated and redesigned all slides to fit., streamlining the copy and recreating various charts and figures from the raw scientific data to ensure consistency between the slides. We also provided Chinese translations of the presentation and factsheet.


Looking for communication support?